4.5 Article

PTK2-associated gene signature could predict the prognosis of IPF

Related references

Note: Only part of the references are listed.
Article Critical Care Medicine

A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis

Ganesh Raghu et al.

Summary: The efficacy and safety of BG00011, an anti-avb6 IgG1 monoclonal antibody, in the treatment of idiopathic pulmonary fibrosis (IPF) were evaluated in a phase IIb randomized controlled trial. The results showed that there was no significant difference in FVC change from baseline between patients who received BG00011 or placebo at Week 26. However, patients in the BG00011 group showed a worsening trend after Week 26 and serious adverse events occurred more frequently in BG00011 patients, including four deaths. The study suggests that further research is needed to identify new treatment strategies for IPF.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Letter Critical Care Medicine

Randomized Phase IIa Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Biochemistry & Molecular Biology

Nintedanib Inhibits Endothelial Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis via Focal Adhesion Kinase Activity Reduction

Wen-Kuang Yu et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease, and pulmonary endothelial cells may generate pulmonary fibroblasts through endothelial mesenchymal transition (EndoMT), leading to pulmonary fibrosis. The tyrosine kinase receptor inhibitor, nintedanib, has been found to ameliorate bleomycin-induced pulmonary fibrosis and suppress EndoMT in vivo and in vitro models. These findings contribute to a better understanding of the mechanism and signaling pathway of EndoMT, and provide new insights for developing more effective drugs for IPF treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Respiratory System

Neutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary Fibrosis

Andrew Achaiah et al.

Summary: Blood neutrophil and lymphopenia are more sensitive than monocytes as prognostic indicators of disease progression in those with established IPF.

BMJ OPEN RESPIRATORY RESEARCH (2022)

Article Medicine, General & Internal

50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study

Brenda M. Juan Guardela et al.

Summary: Blood transcript levels of 50 genes can be used to predict outcomes in COVID-19 and IPF patients, suggesting common immune responses in both diseases. The 50-gene risk profiles are effective in distinguishing severe from mild COVID-19 and predicting disease progression and mortality.

EBIOMEDICINE (2021)

Review Pharmacology & Pharmacy

Nintedanib for Idiopathic Pulmonary Fibrosis

Abisola Tepede et al.

JOURNAL OF PHARMACY PRACTICE (2019)

Review Medicine, General & Internal

Idiopathic Pulmonary Fibrosis

David J. Lederer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Respiratory System

Blood Biomarkers in Idiopathic Pulmonary Fibrosis

Julien Guiot et al.

Article Critical Care Medicine

Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis

Philip L. Molyneaux et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Editorial Material Biochemistry & Molecular Biology

Innate immune signaling and stem cell renewal in idiopathic pulmonary fibrosis

Paul F. Mercer et al.

NATURE MEDICINE (2016)

Article Respiratory System

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review

John Hutchinson et al.

EUROPEAN RESPIRATORY JOURNAL (2015)

Article Cell Biology

Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis

Alyssa D. Gregory et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2015)

Article Respiratory System

A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis

Yong Huang et al.

BMC PULMONARY MEDICINE (2015)

Article Critical Care Medicine

Future Directions in Idiopathic Pulmonary Fibrosis Research

Timothy S. Blackwell et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

Article Medicine, General & Internal

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Critical Care Medicine

The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis

David N. O'Dwyer et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Article Biochemistry & Molecular Biology

Antifibrotic Effects of Focal Adhesion Kinase Inhibitor in Bleomycin-Induced Pulmonary Fibrosis in Mice

Katsuhiro Kinoshita et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)

Article Medicine, Research & Experimental

Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis

Yong Zhou et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Biochemistry & Molecular Biology

Matrix Stiffness-Induced Myofibroblast Differentiation Is Mediated by Intrinsic Mechanotransduction

Xiangwei Huang et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)

Article Genetics & Heredity

Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle

Eric B. Meltzer et al.

BMC MEDICAL GENOMICS (2011)

Article Medicine, General & Internal

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

Luca Richeldi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Cell Biology

Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression

Fei Liu et al.

JOURNAL OF CELL BIOLOGY (2010)

Article Respiratory System

Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?

T. M. Maher et al.

EUROPEAN RESPIRATORY JOURNAL (2007)

Article Critical Care Medicine

Early interstitial lung disease in familial pulmonary fibrosis

Ivan O. Rosas et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Article Respiratory System

Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis

N. I. Chaudhary et al.

EUROPEAN RESPIRATORY JOURNAL (2007)

Article Medicine, Research & Experimental

Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice

X Peng et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Critical Care Medicine

The myofibroblast in pulmonary fibrosis

SH Phan

CHEST (2002)

Article Critical Care Medicine

Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model

TE King et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)